Comparative Study Between the Effect of Dexmedetomidine ,Midazolam or Bupivacaine Packing During FESS on Surgical Field Visualization

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

November 1, 2025

Study Completion Date

December 1, 2025

Conditions
Surgical Hemostasis
Interventions
DRUG

Saline

Group I (Group C): (control group) Patients in this group will receive only 5 ml of intranasal saline.

DRUG

Dexmedetomidine

Group II (Group D): Patients in this group will receive only intranasal Dexmedetomidine (1 mcg/kg) made up to 5 ml in normal saline.

DRUG

Midazolam

Group III (Group M): Patients in this group will receive only intranasal midazolam (0.2 mg/kg) made up to 5 ml in normal saline.

DRUG

Bupivacaine

Group IV (Group B): Patients in this group will receive only intranasal bupivacaine (0.5% solution) 5 ml.

Trial Locations (1)

61511

Faculty of Medicine, Minya

All Listed Sponsors
lead

Minia University

OTHER